CNMB3: A Potential Drug Target and Biomarker for Muscle-Related Diseases

Target Name: KCNMB3

NCBI ID: G27094

KCNMB3

CNMB3: A Potential Drug Target and Biomarker for Muscle-Related Diseases

KCNMB3, also known as BK channel subunit beta-3, is a protein that plays a critical role in the function of skeletal muscles. It is a subunit of the BK channels, which are responsible for muscle contractions. The BK channels are composed of two subunits, alpha and beta, and each subunit has a unique structure that allows them to interact with different muscles and trigger muscle contractions.

KCNMB3 is a 24-kDa protein that is expressed in a variety of tissues, including muscle, heart, and brain. It is primarily localized to the myofibers, which are the fibers that make up muscle tissue. It is involved in the regulation of muscle contractions and has been implicated in a number of diseases, including muscle weakness, muscle fatigue, and myopathies.

Drug Target Potential

KCNMB3 is a drug target of interest due to its involvement in muscle physiology and its potential to modulate muscle function. Several studies have suggested that modifying the expression and function of CNMB3 could be a useful strategy for treating muscle-related diseases.

One potential mechanism by which CNMB3 could be targeted is through its role in muscle contractions. Muscle contractions are regulated by a complex interplay of factors, including the activity of the BK channels. Studies have shown that CNMB3 plays a critical role in the regulation of muscle contractions and that alterations in its expression levels can have a significant impact on muscle function.

In addition to its role in muscle contractions, CNMB3 is also involved in the regulation of muscle fibers growth and differentiation. muscle fibers are the structural units that make up muscle tissue and they play a critical role in muscle function. The regulation of muscle fibers growth and differentiation is critical for maintaining muscle mass and function, and alterations in this process have been implicated in a number of diseases, including muscle dystrophy.

KCNMB3 has also been shown to play a role in the regulation of muscle inflammation and muscle repair. muscle inflammation and muscle repair are critical for maintaining muscle health and function, and alterations in these processes have been implicated in a number of diseases, including muscle weakness and myopathies.

Biomarker Potential

The expression and function of CNMB3 are also potential biomarkers for a number of muscle-related diseases. The regulation of muscle contractions is a critical aspect of muscle physiology, and alterations in this process have been implicated in a number of diseases, including muscle weakness, muscle fatigue, and myopathies.

Studies have shown that CNMB3 is downregulated in muscle samples from patients with muscle-related diseases, and that this downregulation is associated with decreased muscle function. Additionally, studies have shown that CNMB3 is upregulated in muscle samples from animals that have been treated with muscle-regenerating agents, which suggests that it may be a useful biomarker for tracking muscle regeneration.

Conclusion

In conclusion, CNMB3 is a protein that plays a critical role in the function of skeletal muscles and has been implicated in a number of diseases, including muscle weakness, muscle fatigue, and myopathies. Its potential as a drug target and biomarker makes it an attractive target for further research in the field of muscle physiology and disease. Further studies are needed to fully understand the role of CNMB3 in muscle physiology and disease and to develop effective treatments based on this understanding.

Protein Name: Potassium Calcium-activated Channel Subfamily M Regulatory Beta Subunit 3

Functions: Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Alters the functional properties of the current expressed by the KCNMA1 channel. Isoform 2, isoform 3 and isoform 4 partially inactivate the current of KCNBMA. Isoform 4 induces a fast and incomplete inactivation of KCNMA1 channel that is detectable only at large depolarizations. In contrast, isoform 1 does not induce detectable inactivation of KCNMA1. Two or more subunits of KCNMB3 are required to block the KCNMA1 tetramer

The "KCNMB3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNMB3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets